Literature DB >> 4349107

Trial of gaviscon in the treatment of gastro-oesophageal reflux of infancy.

A P Weldon, M J Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4349107     DOI： 10.1111/j.1440-1754.1972.tb01837.x

Source DB:  PubMed          Journal:  Aust Paediatr J        ISSN： 0004-993X


× No keyword cloud information.
  4 in total

1.  Contribution of fibreoptic endoscopy to diagnosis and management of children with gastro-oesophageal reflux.

Authors:  P P Forget; M Meradji
Journal:  Arch Dis Child       Date:  1976-01       Impact factor: 3.791

2.  Alginates: From the ocean to gastroesophageal reflux disease treatment.

Authors:  Serhat Bor; İsmail Hakkı Kalkan; Altay Çelebi; Dinç Dinçer; Filiz Akyüz; Peter Dettmar; Hasan Özen
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852

3.  Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children.

Authors:  J P Buts; C Barudi; J B Otte
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

4.  Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH.

Authors:  R Del Buono; T G Wenzl; G Ball; S Keady; M Thomson
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.